IL151564A0 - Potassium channel proteins - Google Patents

Potassium channel proteins

Info

Publication number
IL151564A0
IL151564A0 IL15156401A IL15156401A IL151564A0 IL 151564 A0 IL151564 A0 IL 151564A0 IL 15156401 A IL15156401 A IL 15156401A IL 15156401 A IL15156401 A IL 15156401A IL 151564 A0 IL151564 A0 IL 151564A0
Authority
IL
Israel
Prior art keywords
kcnb
potassium channel
activity
channel proteins
modulate
Prior art date
Application number
IL15156401A
Other languages
English (en)
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of IL151564A0 publication Critical patent/IL151564A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
IL15156401A 2000-03-03 2001-03-02 Potassium channel proteins IL151564A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18691500P 2000-03-03 2000-03-03
PCT/US2001/006801 WO2001066741A2 (en) 2000-03-03 2001-03-02 Kcnb: a novel potassium channel protein

Publications (1)

Publication Number Publication Date
IL151564A0 true IL151564A0 (en) 2003-04-10

Family

ID=22686808

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15156401A IL151564A0 (en) 2000-03-03 2001-03-02 Potassium channel proteins
IL151564A IL151564A (en) 2000-03-03 2002-09-02 Potassium channel proteins

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151564A IL151564A (en) 2000-03-03 2002-09-02 Potassium channel proteins

Country Status (12)

Country Link
US (2) US7462465B2 (https=)
EP (1) EP1266003B1 (https=)
JP (2) JP2004500825A (https=)
CN (1) CN1426468A (https=)
AT (1) ATE538201T1 (https=)
AU (2) AU5079401A (https=)
CA (1) CA2401906C (https=)
ES (1) ES2378417T3 (https=)
IL (2) IL151564A0 (https=)
NZ (1) NZ521205A (https=)
WO (1) WO2001066741A2 (https=)
ZA (1) ZA200206999B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060246432A1 (en) * 2001-12-31 2006-11-02 Shuster Samuel J Methods and materials for modulating task-3
WO2005052586A2 (en) * 2003-11-27 2005-06-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
WO2005075510A1 (en) * 2004-02-04 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9)
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744730B1 (fr) * 1996-02-08 1998-04-17 Centre Nat Rech Scient Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues
EP1051485A1 (en) 1998-01-27 2000-11-15 Smithkline Beecham Plc Trek-1 like two pore potassium channel
WO2000000610A2 (en) 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
WO2000027871A2 (en) 1998-11-09 2000-05-18 Centre National De La Recherche Scientifique - Cnrs New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
EP1165777A2 (en) * 1999-03-05 2002-01-02 Smithkline Beecham Plc Genes encoding human potassium channel proteins
US20020137202A1 (en) * 1999-12-21 2002-09-26 Catherine Burgess Novel proteins and nucleic acids encoding same
AU3087801A (en) 2000-02-04 2001-08-14 Molecular Dynamics Inc Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
AU2001249906A1 (en) 2000-04-06 2001-10-23 Incyte Genomics, Inc. Human transporters and ion channels
WO2002026983A2 (en) 2000-09-25 2002-04-04 Millennium Pharmaceuticals, Inc. 56115, a novel human twik potassium channel and uses therefor

Also Published As

Publication number Publication date
AU5079401A (en) 2001-09-17
US20080234470A1 (en) 2008-09-25
NZ521205A (en) 2005-09-30
IL151564A (en) 2008-11-03
JP2011115169A (ja) 2011-06-16
US7462465B2 (en) 2008-12-09
WO2001066741A2 (en) 2001-09-13
CA2401906C (en) 2011-07-19
EP1266003B1 (en) 2011-12-21
US20020102676A1 (en) 2002-08-01
WO2001066741A3 (en) 2002-04-04
CN1426468A (zh) 2003-06-25
CA2401906A1 (en) 2001-09-13
ATE538201T1 (de) 2012-01-15
WO2001066741A9 (en) 2003-03-06
EP1266003A2 (en) 2002-12-18
ES2378417T3 (es) 2012-04-12
JP2004500825A (ja) 2004-01-15
ZA200206999B (en) 2004-05-31
AU2001250794B2 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
AU2085502A (en) Diagnosis and treatment of disease
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE69735445D1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
AU4981101A (en) Subtilisin variants
WO2003022028A3 (en) Methods, reagents, kits and apparatus for protein function analysis
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
BRPI0001536B8 (https=)
DE50109723D1 (de) Nachweis und identifikation von bakteriengruppen
ATE439441T1 (de) Veränderte, fluoreszierende proteine
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
IL179441A0 (en) Hif prolyl hydroxylase activity assay
TR200200667T2 (tr) Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları.
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
IL151564A0 (en) Potassium channel proteins
DE60025704D1 (de) Das goodpasture-antigen bindende protein
DE50105263D1 (de) Verfahren zur analyse von proteinen
DE69734586D1 (de) Retinoid-metabolisierendes protein
Li et al. Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal Streptococcus and Actinomyces species
WO2001079272A3 (en) Sitosterolemia susceptibility gene (ssg): compositions and methods of use
WO2001031009A3 (en) Chandra: a th1-specific gene
BR0108767A (pt) Adenilciclase recombinante, polinucleotìdeo, vetor, processos para a detecção de atividade proteolìtica de uma molécula e da resistência a um inibidor, de uma molécula com atividade proteolìtica e de identificação de moléculas com atividade proteolìtica sìtio-especìfica, kit de diagnóstico, utilização de uma adenilciclase, e, cepa bacteriana
EP1241269A3 (en) Method for detecting REG-like protein and nucleic acids coding therefor
MXPA05008925A (es) Ciclooxigenasa-3 humana y usos de la misma.